The net profit of Healthcare Services rose 46% year-on-year to ₹257 crore, while Apollo Health & Lifestyle Limited posted a net loss of ₹23 crore. Apollo HealthCo. logged a net loss of ₹89 crore, as per a statement from Apollo Hospitals. (File photo used for representational purpose only.)
| Photo Credit: The Hindu
The consolidated net profit of Apollo Hospitals Enterprise Limited (AHEL) for the fourth-quarter ended March 2023, grew 50% year-on-year to ₹146 crore.
The net profit of Healthcare Services (HCS) rose 46% year-on-year to ₹257 crore, while Apollo Health & Lifestyle Limited (AHLL) posted a net loss of ₹23 crore. Apollo HealthCo. (AHL) logged a net loss of ₹89 crore, a statement from the hospital said.
Apollo Hospitals Enterprise Limited Group CFO Krishnan Akhileswaran.
Revenue from operations grew by 21% to ₹4,302 crore, of which HCS accounted for ₹2,195 crore, AHLL ₹309 crore and AHL ₹1,799 crore. The gross merchandise value of Apollo 24/7 was ₹593 crore.
“The results of AHLL are not comparable with the previous year as it included COVID-related revenues,” said Group CFO Krishnan Akhileswaran. “The segment should get to 10% operational EBITDA margins in FY24 and higher in the following year. Also, Apollo HealthCo is on track for Q4 FY24 break-even.“
According to him, revenue from diagnostic business is expected to touch ₹500 crore this fiscal from ₹383 crore. Besides, the company is focussed on improving the occupancy level in hospitals from 65% to 70% in the coming year which should further expand the hospital margins.
“We are on track to add 2,000 beds over the next four years with a capital outlay of ₹3,000 crore which should predominantly come from internal accruals,” he added.
As on March, Apollo Hospitals had total 70 hospitals with 9,957 operating beds across the network (including 562 beds in AHLL), out of which 14 hospitals were new with 2,384 operating beds. The board declared final dividend of ₹9 per share.